Karina Helena Morais Cardozo
Papers
3
Total Citations
155
H-Index
3
About
Karina Helena Morais Cardozo is a Brazilian researcher whose work sits at the cutting edge of clinical proteomics and mass spectrometry-based diagnostics. She rose to international prominence during the COVID-19 pandemic through her pioneering contributions to rapid, scalable detection of SARS-CoV-2. Her most celebrated work, published in 2020 and accumulating 126 citations, established a high-throughput targeted proteomics platform capable of detecting the SARS-CoV-2 nucleoprotein in large clinical sample cohorts — a landmark achievement at a time when the world urgently needed robust testing infrastructure. By harnessing tandem mass spectrometry, Cardozo and her collaborators demonstrated that proteomics-based methods could serve as fast and cost-effective alternatives to conventional molecular diagnostics, a contribution further reinforced by her additional publications on low-cost peptide detection in clinical settings. Her research directly addressed a critical public health challenge, offering scalable solutions for population-level screening during a global crisis. Cardozo's body of work exemplifies how analytical chemistry and clinical science can converge to produce real-world, life-saving impact, making her a vital voice in the fields of infectious disease diagnostics and biomedical mass spectrometry.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3